The Nation - News from Aug. 30, 1985

Researchers reported in the British journal Nature that they have taken a major stride toward identifying the genetic defect that causes the most common form of deadly muscular dystrophy. The work by a team at Children’s Hospital in Boston may help lead to development of a treatment for Duchenne muscular dystrophy, other experts said. In addition, it will provide a better test for finding carriers of the defect that causes the disease and for performing prenatal diagnosis, the experts said.